Stathmin-like 2, a developmentally-associated neuronal marker, is expressed and modulated during osteogenesis of human mesenchymal stem cells

Biochemical and Biophysical Research Communications

Volumn 374, Issue 1, 2008, Pages 64-68

  Chiellini, Chiara ^a   Grenningloh, Gabriele ^b   Cochet, Olivia ^a   Scheideler, Marcel ^c   Trajanoski, Zlatko ^c   Ailhaud, Gérard ^a   Dani, Christian ^a   Amri, Ez Zoubir ^a  

^a UNIVERSITÉ CÔTE D'AZUR   (France)

^b UNIVERSITY OF LAUSANNE   (Switzerland)

^c GRAZ UNIVERSITY OF TECHNOLOGY   (Austria)

Author keywords

Differentiation; Osteoblast; Stathmin like 2; Stem cells

Indexed keywords

4 (1 AMINOETHYL) N (4 PYRIDYL)CYCLOHEXANECARBOXAMIDE; CELL MARKER; DEXAMETHASONE; RHO KINASE INHIBITOR; STATHMIN; STATHMIN LIKE 2;

ADIPOGENESIS; ARTICLE; BONE DEVELOPMENT; CELL DIFFERENTIATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOSKELETON; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MESENCHYMAL STEM CELL; OSTEOBLAST; PRIORITY JOURNAL; PROTEIN EXPRESSION; WESTERN BLOTTING;

ADIPOCYTES; ADIPOGENESIS; ADIPOSE TISSUE; AMIDES; BIOLOGICAL MARKERS; BONE MARROW CELLS; CYTOSOL; DEXAMETHASONE; GOLGI APPARATUS; HUMANS; MEMBRANE PROTEINS; MESENCHYMAL STEM CELLS; NEURONS; OSTEOBLASTS; OSTEOGENESIS; PROTEIN KINASE INHIBITORS; PYRIDINES; RHO-ASSOCIATED KINASES; RNA, MESSENGER;

EID: 47749125320     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2008.06.121     Document Type: Article

References (40)

1. Pittenger M.F., Mackay A.M., Beck S.C., Jaiswal R.K., Douglas R., Mosca J.D., Moorman M.A., Simonetti D.W., Craig S., and Marshak D.R. Multilineage potential of adult human mesenchymal stem cells. Science 284 (1999) 143-147
2. Rodriguez A.M., Pisani D., Dechesne C.A., Turc-Carel C., Kurzenne J.Y., Wdziekonski B., Villageois A., Bagnis C., Breittmayer J.P., Groux H., Ailhaud G., and Dani C. Transplantation of a multipotent cell population from human adipose tissue induces dystrophin expression in the immunocompetent mdx mouse. J. Exp. Med. 201 (2005) 1397-1405
3. Bianco P., and Gehron Robey P. Marrow stromal stem cells. J. Clin. Invest. 105 (2000) 1663-1668
4. Hong J.H., Hwang E.S., McManus M.T., Amsterdam A., Tian Y., Kalmukova R., Mueller E., Benjamin T., Spiegelman B.M., Sharp P.A., Hopkins N., and Yaffe M.B. TAZ a transcriptional modulator of mesenchymal stem cell differentiation. Science 309 (2005) 1074-1078
5. Engler A.J., Sen S., Sweeney H.L., and Discher D.E. Matrix elasticity directs stem cell lineage specification. Cell 126 (2006) 677-689
6. McBeath R., Pirone D.M., Nelson C.M., Bhadriraju K., and Chen C.S. Cell shape, cytoskeletal tension, and RhoA regulate stem cell lineage commitment. Dev. Cell 6 (2004) 483-495
7. Roskelley C.D., Desprez P.Y., and Bissell M.J. Extracellular matrix-dependent tissue-specific gene expression in mammary epithelial cells requires both physical and biochemical signal transduction. Proc. Natl. Acad. Sci. USA 91 (1994) 12378-12382
8. Rodriguez A.M., Elabd C., Delteil F., Astier J., Vernochet C., Saint-Marc P., Guesnet J., Guezennec A., Amri E.Z., Dani C., and Ailhaud G. Adipocyte differentiation of multipotent cells established from human adipose tissue. Biochem. Biophys. Res. Commun. 315 (2004) 255-263
9. Zaragosi L.E., Ailhaud G., and Dani C. Autocrine fibroblast growth factor 2 signaling is critical for self-renewal of human multipotent adipose-derived stem cells. Stem Cells 24 (2006) 2412-2419
10. Elabd C., Chiellini C., Massoudi A., Cochet O., Zaragosi L.E., Trojani C., Michiels J.F., Weiss P., Carle G., Rochet N., Dechesne C.A., Ailhaud G., Dani C., and Amri E.Z. Human adipose tissue-derived multipotent stem cells differentiate in vitro and in vivo into osteocyte-like cells. Biochem. Biophys. Res. Commun. 361 (2007) 342-348
11. Kulterer B., Friedl G., Jandrositz A., Sanchez-Cabo F., Prokesch A., Paar C., Scheideler M., Windhager R., Preisegger K.H., and Trajanoski Z. Gene expression profiling of human mesenchymal stem cells derived from bone marrow during expansion and osteoblast differentiation. BMC Genomics 8 (2007) 70
12. Di Paolo G., Antonsson B., Kassel D., Riederer B.M., and Grenningloh G. Phosphorylation regulates the microtubule-destabilizing activity of stathmin and its interaction with tubulin. FEBS Lett. 416 (1997) 149-152
13. Riederer B.M., Pellier V., Antonsson B., Di Paolo G., Stimpson S.A., Lutjens R., Catsicas S., and Grenningloh G. Regulation of microtubule dynamics by the neuronal growth-associated protein SCG10. Proc. Natl. Acad. Sci. USA 94 (1997) 741-745
14. Curmi P.A., Gavet O., Charbaut E., Ozon S., Lachkar-Colmerauer S., Manceau V., Siavoshian S., Maucuer A., and Sobel A. Stathmin and its phosphoprotein family: general properties, biochemical and functional interaction with tubulin. Cell Struct. Funct. 24 (1999) 345-357
15. Gavet O., Ozon S., Manceau V., Lawler S., Curmi P., and Sobel A. The stathmin phosphoprotein family: intracellular localization and effects on the microtubule network. J. Cell Sci. 111 pt. 22 (1998) 3333-3346
16. Sobel A. Stathmin: a relay phosphoprotein for multiple signal transduction?. Trends Biochem. Sci. 16 (1991) 301-305
17. Di Paolo G., Lutjens R., Osen-Sand A., Sobel A., Catsicas S., and Grenningloh G. Differential distribution of stathmin and SCG10 in developing neurons in culture. J. Neurosci. Res. 50 (1997) 1000-1009
18. Belmont L.D., and Mitchison T.J. Identification of a protein that interacts with tubulin dimers and increases the catastrophe rate of microtubules. Cell 84 (1996) 623-631
19. Mori N., and Morii H. SCG10-related neuronal growth-associated proteins in neural development plasticity degeneration and aging. J. Neurosci. Res. 70 (2002) 264-273
20. Grenningloh G., Soehrman S., Bondallaz P., Ruchti E., and Cadas H. Role of the microtubule destabilizing proteins SCG10 and stathmin in neuronal growth. J. Neurobiol. 58 (2004) 60-69
21. Di Paolo G., Pellier V., Catsicas M., Antonsson B., Catsicas S., and Grenningloh G. The phosphoprotein stathmin is essential for nerve growth factor-stimulated differentiation. J. Cell Biol. 133 (1996) 1383-1390
22. Antonsson B., Kassel D.B., Di Paolo G., Lutjens R., Riederer B.M., and Grenningloh G. Identification of in vitro phosphorylation sites in the growth cone protein SCG10. Effect of phosphorylation site mutants on microtubule-destabilizing activity. J. Biol. Chem. 273 (1998) 8439-8446
23. Stein R., Orit S., and Anderson D.J. The induction of a neural-specific gene, SCG10, by nerve growth factor in PC12 cells is transcriptional, protein synthesis dependent, and glucocorticoid inhibitable. Dev. Biol. 127 (1988) 316-325
24. Kumar R., and Haugen J.D. Human and rat osteoblast-like cells express stathmin a growth-regulatory protein. Biochem. Biophys. Res. Commun. 201 (1994) 861-865
25. Charbaut E., Chauvin S., Enslen H., Zamaroczy S., and Sobel A. Two separate motifs cooperate to target stathmin-related proteins to the Golgi complex. J. Cell Sci. 118 (2005) 2313-2323
26. Di Paolo G., Lutjens R., Pellier V., Stimpson S.A., Beuchat M.H., Catsicas S., and Grenningloh G. Targeting of SCG10 to the area of the Golgi complex is mediated by its NH2-terminal region. J. Biol. Chem. 272 (1997) 5175-5182
27. Lutjens R., Igarashi M., Pellier V., Blasey H., Di Paolo G., Ruchti E., Pfulg C., Staple J.K., Catsicas S., and Grenningloh G. Localization and targeting of SCG10 to the trans-Golgi apparatus and growth cone vesicles. Eur. J. Neurosci. 12 (2000) 2224-2234
28. Stein R., Mori N., Matthews K., Lo L.C., and Anderson D.J. The NGF-inducible SCG10 mRNA encodes a novel membrane-bound protein present in growth cones and abundant in developing neurons. Neuron 1 (1988) 463-476
29. Lee P.G., and Koo P.H. Rat alpha1-macroglobulin enhances nerve growth factor-promoted neurite outgrowth TrkA phosphorylation and gene expression of pheochromocytoma PC12 cells. J. Neurochem. 74 (2000) 81-91
30. Mogi M., Kondo A., Kinpara K., and Togari A. Anti-apoptotic action of nerve growth factor in mouse osteoblastic cell line. Life Sci. 67 (2000) 1197-1206
31. Pinski J., Weeraratna A., Uzgare A.R., Arnold J.T., Denmeade S.R., and Isaacs J.T. Trk receptor inhibition induces apoptosis of proliferating but not quiescent human osteoblasts. Cancer Res. 62 (2002) 986-989
32. Weinstein R.S., Jilka R.L., Parfitt A.M., and Manolagas S.C. Inhibition of osteoblastogenesis and promotion of apoptosis of osteoblasts and osteocytes by glucocorticoids. Potential mechanisms of their deleterious effects on bone. J. Clin. Invest. 102 (1998) 274-282
33. Saag K.G. Glucocorticoid-induced osteoporosis. Endocrinol. Metab. Clin. North Am. 32 (2003) 135-157 vi
34. Jia D., O'Brien C.A., Stewart S.A., Manolagas S.C., and Weinstein R.S. Glucocorticoids act directly on osteoclasts to increase their life span and reduce bone density. Endocrinology 147 (2006) 5592-5599
35. Bellows C.G., Aubin J.E., and Heersche J.N. Physiological concentrations of glucocorticoids stimulate formation of bone nodules from isolated rat calvaria cells in vitro. Endocrinology 121 (1987) 1985-1992
36. Jaiswal N., Haynesworth S.E., Caplan A.I., and Bruder S.P. Osteogenic differentiation of purified culture-expanded human mesenchymal stem cells in vitro. J. Cell. Biochem. 64 (1997) 295-312
37. Justesen J., Stenderup K., Eriksen E.F., and Kassem M. Maintenance of osteoblastic and adipocytic differentiation potential with age and osteoporosis in human marrow stromal cell cultures. Calcif. Tissue Int. 71 (2002) 36-44
38. Gimble J.M., Zvonic S., Floyd Z.E., Kassem M., and Nuttall M.E. Playing with bone and fat. J. Cell. Biochem. 98 (2006) 251-266
39. Li X., Cui Q., Kao C., Wang G.J., and Balian G. Lovastatin inhibits adipogenic and stimulates osteogenic differentiation by suppressing PPARgamma2 and increasing Cbfa1/Runx2 expression in bone marrow mesenchymal cell cultures. Bone 33 (2003) 652-659
40. Verma S., Rajaratnam J.H., Denton J., Hoyland J.A., and Byers R.J. Adipocytic proportion of bone marrow is inversely related to bone formation in osteoporosis. J. Clin. Pathol. 55 (2002) 693-698